ISRG has always been a shark so there's no reason to expect that to change. My theory is while SPORT will be the only foreseeable single port competitor, SPORT's sell to administrators and physicians of acyte care facilites will be tough because they can just upgrade their Xi and not have 2x the capital, service, disposables and inventory management overhead expense. But since Xis are not likely to be sold ever to a small outpatient surg center, sport can leverage that niche.
News 
Market Data 
Discover 
